- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07575126
Comparison of Qigong and Otago in Patient With Diabetic Neuropathy
Comparison of Qigong and Otago on Agility, Balance, Gait, and Quality of Life in Patients With Diabetic Neuropathy
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Muneeb Khan, PhD
- Telefoonnummer: +92336799611
- E-mail: muneeb.khan@riphah.edu.pk
Studie Locaties
-
-
Punjab Province
-
Guiranwala, Punjab Province, Pakistan, 54500
- DHQ Gujranwala
-
Contact:
- Javeria Ghazal, MS
- Telefoonnummer: +923335154664
-
Hoofdonderzoeker:
- Junaid Raza, MS
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Physician-diagnosed type 2 diabetes without gender bias, with peripheral neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire score of 5 or greater)
- Type 2 diabetic peripheral neuropathy patients
- The ability to walk independently for 10 m
- Having score between 46 to 52 (out of a total of 56 points) on the BBS
Exclusion Criteria:
- Fracture of the lower limb within the 6 months before the study (15)
- Diabetic ulcer, infection or partial amputation in feet (15)
- Disease or functional impairment of auditory, vestibular system (16)
- Any other medical conditions that would confound assessment of neuropathy such as malignancy, other neurological or orthopedic impairments (such as stroke, poliomyelitis, rheumatoid arthritis, prosthesis, or severe osteoarthritis), major vascular complications (venous or arterial ulcers), severe retinopathy, or severe nephropathy that causes edema or needs hemodialysis (17)
- Dementia or inability to give consistent information (18)
- History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Qigong Balance
|
Quigong Balance Exercises 3 times per week for 60 minutes per session Open the Flow: Focus on fluid arm movements to enhance relaxation and improve circulation. Shaking Exercise: A full-body shake to release tension and promote energy flow. Lifting the Ball: Alternating arm movements simulating lifting a ball to improve upper body strength and coordination. Playing with Water: Slow, flowing movements that enhance balance and mindfulness. Weight Shifting and Balance Exercises: Stand with feet hip-width apart, shifting weight slowly from one leg to the other, holding each position for 10-15 seconds to engage stabilizing muscles in the legs and improve proprioception. Leg Lifts and Extensions: Perform controlled leg lifts (front, side, and back) to strengthen the quadriceps, hamstrings, and hip abductors. |
|
Actieve vergelijker: Otago Balance
|
Otago (Strengthening) Balance: Sit-to-stand exercises: to improve leg strength. Heel raises: to enhance calf strength. Toe stands: for improving foot stability. Balance Training: Single-leg stands: to enhance balance. Tandem walking: along a straight line. Side leg raises: to strengthen hip muscles 3 times per week for 60 minutes per session |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Agility T-Test
Tijdsspanne: 12th week
|
The Agility T-Test is a performance-based assessment that measures an individual's agility and ability to change direction quickly.
It involves a sequence where the participant runs to a designated point, makes sharp turns around markers in a T-shaped layout, and returns to the starting position.
|
12th week
|
|
Berg Balance Scale
Tijdsspanne: 12th week
|
is the gold standard test for static and dynamic balance abilities.
The BBS is used to measure ability to maintain balance while doing functional task search as reach, standing position and transferences.
It is a valid instrument used for the evaluation of effectiveness of interventions with quantitative description of function in clinical practice as well as research.
It consists of 14 items including simple balance tasks from everyday life.
|
12th week
|
|
Functional Reach Test
Tijdsspanne: 12th week
|
FRT is a single item test for dynamic balance and acts as a quick screen for balance problems in older adults.
The distance between the lengths of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support is measured.
A score of 6 inches or less indicates a significant increased risk for falls.
A score between 6-10 inches indicates a moderate risk for falls.
the Functional Reach Test (FRT) demonstrates an ICC of approximately 0.85 to 0.94
|
12th week
|
|
Gait Speed Test
Tijdsspanne: 12th week
|
The Gait Speed Test measures the time it takes for an individual to walk a specific distance, usually 10 meters, at their usual pace.
It has demonstrated strong validity and reliability, with an Intra class Correlation Coefficient (ICC) often exceeding 0.90
|
12th week
|
|
10-Meter Walk Test
Tijdsspanne: 12th week
|
The 10-Meter Walk Test involves timing a participant as they walk a distance of 10 meters at their comfortable pace.
It assesses gait speed, which is an important indicator of mobility and overall functional ability.
|
12th week
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Javeria Ghazal, MS, Riphah International University
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- REC/RCR &AHS/24/0297
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .